---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-009711"
form_type: "8-K"
ticker: "CBIO"
cik: "0001253689"
company_name: "CRESCENT BIOPHARMA, INC."
filed_at: "2022-06-03T23:59:59+00:00"
generated_at: "2026-06-25T04:38:13.043225+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# GlycoMimetics receives Nasdaq minimum bid price deficiency notice

## Summary
- Bid price below $1.00 for 30 consecutive business days; 180-day cure period until Nov 28, 2022.
- Compliance requires closing bid price at or above $1.00 for at least 10 consecutive business days.
- If not cured, Company may transfer to Nasdaq Capital Market for additional 180-day period if eligible.
- Noncompliance has no immediate effect on listing or trading of common stock on The Nasdaq Global Market.

## SEC filing metadata
- accession: 0001558370-22-009711
- form_type: 8-K
- ticker: CBIO
- cik: 0001253689
- company_name: CRESCENT BIOPHARMA, INC.
- filed_at: 2022-06-03T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1253689/000155837022009711/0001558370-22-009711-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1253689/000155837022009711/glyc-20220531x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-009711
- JSON: https://secwatch.observer/filing/0001558370-22-009711.json
- Plain text: https://secwatch.observer/filing/0001558370-22-009711.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.